Biotoxtech Co. Ltd Total Liabilities
Biotoxtech Co. Ltd total liabilities. Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has total liabilities worth ₩100.81 Billion KRW (≈ $68.32 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 086040 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Biotoxtech Co. Ltd (2011–2025)
Total liabilities of Biotoxtech Co. Ltd from 2011 to 2025. This chart illustrates how Biotoxtech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 086040 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Biotoxtech Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Biotoxtech Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Celulosa Argentina SA
BA:CELU
|
Argentina | AR$343.59 Billion |
|
Deep Value Driller AS
OL:DVD
|
Norway | Nkr166.61 Million |
|
Ken Holdings Bhd
KLSE:7323
|
Malaysia | RM51.02 Million |
|
Radiant Globaltech Bhd
KLSE:0202
|
Malaysia | RM67.85 Million |
|
Green Resources Public Company Limited
BK:GREEN
|
Thailand | ฿195.49 Million |
|
2020 Bulkers Ltd
OL:2020
|
Norway | Nkr115.00 Million |
|
ELUON Corporation
KQ:065440
|
Korea | ₩26.80 Billion |
|
Fortuna Metals Limited
AU:FUN
|
Australia | AU$408.90K |
Liability Composition Analysis (2011–2025)
This chart breaks down Biotoxtech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 086040 total assets.
Liquidity & Leverage Metrics
Biotoxtech Co. Ltd Total Liabilities Ratios Explained
Biotoxtech Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biotoxtech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biotoxtech Co. Ltd (2011–2025)
The table below shows the annual total liabilities of Biotoxtech Co. Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩99.68 Billion ≈ $67.55 Million |
+3.71% |
| 2024-12-31 | ₩96.11 Billion ≈ $65.13 Million |
-2.73% |
| 2023-12-31 | ₩98.80 Billion ≈ $66.96 Million |
+21.28% |
| 2022-12-31 | ₩81.47 Billion ≈ $55.21 Million |
+64.25% |
| 2021-12-31 | ₩49.60 Billion ≈ $33.61 Million |
+64.61% |
| 2020-12-31 | ₩30.13 Billion ≈ $20.42 Million |
+0.49% |
| 2019-12-31 | ₩29.98 Billion ≈ $20.32 Million |
-5.95% |
| 2018-12-31 | ₩31.88 Billion ≈ $21.61 Million |
-3.91% |
| 2017-12-31 | ₩33.18 Billion ≈ $22.49 Million |
+41.39% |
| 2016-12-31 | ₩23.47 Billion ≈ $15.90 Million |
+7.67% |
| 2015-12-31 | ₩21.79 Billion ≈ $14.77 Million |
+3.04% |
| 2014-12-31 | ₩21.15 Billion ≈ $14.33 Million |
+2.21% |
| 2013-12-31 | ₩20.69 Billion ≈ $14.02 Million |
+10.34% |
| 2012-12-31 | ₩18.75 Billion ≈ $12.71 Million |
-16.47% |
| 2011-12-31 | ₩22.45 Billion ≈ $15.22 Million |
-- |
About Biotoxtech Co. Ltd
Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and b… Read more